Category: Elisa Kits

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

We evaluate the clinical validity of the pharmacogenomic test combination and the implementation guidelines for single clinical pharmacogenetics (CPIC) on patient outcomes and blood levels […]

Continue reading

Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis

One target drug for plaque psoriasis treatment is apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor selective. In this study, 34 patients with moderate and […]

Continue reading